R. Glynne-Jones, “A Phase I/ II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES)”, acbr, vol. 4, no. 4, pp. 394–412, Aug. 2020.